Clinical Outcomes of Male Subjects With Moderate COPD Based on Maximum Mid-Expiratory Flow

References

1. 1.↵
   1. Vogelmeier CF,
   2. Criner GJ,
   3. Martinez FJ,
   4. Anzueto A,
   5. Barnes PJ,
   6. Bourbeau J,
   7. et al

   . Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med 2017;195(5):557-582.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Hogg JC,
   2. Chu F,
   3. Utokaparch S,
   4. Woods R,
   5. Elliott WM,
   6. Buzatu L,
   7. et al

   . The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350(26):2645-2653.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Pennock BE,
   2. Rogers RM,
   3. McCaffree DR

   . Changes in measured spirometric indices. What is significant? Chest 1981;80(1):97-99.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Herpel LB,
   2. Kanner RE,
   3. Lee SM,
   4. Fessler HE,
   5. Sciurba FC,
   6. Connett JE,
   7. Wise RA

   , National Emphysema Treatment Trial Research Group. Variability of spirometry in chronic obstructive pulmonary disease: results from two clinical trials. Am J Respir Crit Care Med 2006;173(10):1106-1113.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Wegner RE,
   2. Jörres RA,
   3. Kirsten DK,
   4. Magnussen H

   . Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 1994;7(4):725-729.

   OpenUrlAbstract
6. 6.
   1. Wijnhoven HA,
   2. Kriegsman DM,
   3. Hesselink AE,
   4. Penninx BW,
   5. de Haan M

   . Determinants of different dimensions of disease severity in asthma and COPD: pulmonary function and health-related quality of life. Chest 2001;119(4):1034-1042.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Hay JG,
   2. Stone P,
   3. Carter J,
   4. Church S,
   5. Eyre-Brook A,
   6. Pearson MG,
   7. et al

   . Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J 1992;5(6):659-664.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Stockley JA,
   2. Ismail AM,
   3. Hughes SM,
   4. Edgar R,
   5. Stockley RA,
   6. Sapey E

   . Maximal mid-expiratory flow detects early lung disease in α₁-antitrypsin deficiency. Eur Respir J 2017;49(3):1602055.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Piorunek T,
   2. Kostrzewska M,
   3. Stelmach-Mardas M,
   4. Mardas M,
   5. Michalak S,
   6. Goździk-Spychalska J,
   7. Batura-Gabryel H

   . Small airway obstruction in chronic obstructive pulmonary disease: potential parameters for early detection. Adv Exp Med Biol 2017;980:75-82.

   OpenUrl
10. 10.↵
    1. Stewart JI,
    2. Criner GJ

    . The small airways in chronic obstructive pulmonary disease: pathology and effects on disease progression and survival. Curr Opin Pulm Med 2013;19(2):109-115.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Yanai M,
    2. Sekizawa K,
    3. Ohrui T,
    4. Sasaki H,
    5. Takishima T

    . Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol 1992;72(3):1016-1023.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Crisafulli E,
    2. Pisi R,
    3. Aiello M,
    4. Vigna M,
    5. Tzani P,
    6. Torres A,
    7. et al

    . Prevalence of small-airway dysfunction among COPD patients with different GOLD stages and its role in the impact of disease. Respiration 2017;93(1):32-41.

    OpenUrlPubMed
13. 13.↵
    1. Timmins SC,
    2. Diba C,
    3. Farrow CE,
    4. Schoeffel RE,
    5. Berend N,
    6. Salome CM,
    7. King GG

    . The relationship between airflow obstruction, emphysema extent, and small airways function in COPD. Chest 2012;142(2):312-319.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. McDonough JE,
    2. Yuan R,
    3. Suzuki M,
    4. Seyednejad N,
    5. Elliott WM,
    6. Sanchez PG,
    7. et al

    . Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011;365(17):1567-1575.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Laviolette L,
    2. Lacasse Y,
    3. Doucet M,
    4. Lacasse M,
    5. Marquis K,
    6. Saey D,
    7. et al

    . Chronic obstructive pulmonary disease in women. Can Respir J 2007;14(2):93-98.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. de Torres JP,
    2. Casanova C,
    3. Hernández C,
    4. Abreu J,
    5. Aguirre-Jaime A,
    6. Celli BR

    . Gender and COPD in patients attending a pulmonary clinic. Chest 2005;128(4):2012-2016.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. Burgos F,
    5. Casaburi R,
    6. Coates A,
    7. et al

    . Standardisation of spirometry. Eur Respir J 2005;26(2):319-338.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Bestall JC,
    2. Paul EA,
    3. Garrod R,
    4. Garnham R,
    5. Jones PW,
    6. Wedzicha JA

    . Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7):581-586.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111-117.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Craig CL,
    2. Marshall AL,
    3. Sjöström M,
    4. Bauman AE,
    5. Booth ML,
    6. Ainsworth BE,
    7. et al

    . International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35(8):1381-1395.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Krupp LB,
    2. LaRocca NG,
    3. Muir-Nash J,
    4. Steinberg AD

    . The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46(10):1121-1123.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Jones PW,
    2. Quirk FH,
    3. Baveystock CM

    . The St George respiratory questionnaire. Respir Med 1991;85(Suppl B):S25-S37.

    OpenUrl
23. 23.↵
    1. Ware JE,
    2. Kosinski M

    . Interpreting SF-36 summary health measures: a response. Qual Life Res 2001;10(5):405-420.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Field A

    . Discovering statistics using SPSS, 3rd ed. London, UK: Sage Publications Ltd; 2009.
25. 25.↵
    1. Lopes AJ,
    2. Mafort TT

    . Correlations between small airway function, ventilation distribution, and functional exercise capacity in COPD patients. Lung 2014;192(5):653-659.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Burgel PR

    . The role of small airways in obstructive airway diseases. Eur Respir Rev 2011;20(119):23-33.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Mirsadraee M,
    2. Boskabady MH,
    3. Attaran D

    . Diagnosis of chronic obstructive pulmonary disease earlier than current Global Initiative for Obstructive Lung Disease guidelines using a feasible spirometry parameter (maximal-mid expiratory flow/forced vital capacity). Chron Respir Dis 2013;10(4):191-196.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Stockley JA,
    2. Cooper BG,
    3. Stockley RA,
    4. Sapey E

    . Small airways disease: time for a revisit? Int J Chron Obstruct Pulmon Dis 2017;12:2343-2353.

    OpenUrl
29. 29.↵
    1. Haruna A,
    2. Oga T,
    3. Muro S,
    4. Ohara T,
    5. Sato S,
    6. Marumo S,
    7. et al

    . Relationship between peripheral airway function and patient-reported outcomes in COPD: a cross-sectional study. BMC Pulm Med 2010;10:10.

    OpenUrlCrossRefPubMed
30. 30.↵
    1. Small SP,
    2. Lamb M

    . Measurement of fatigue in chronic obstructive pulmonary disease and in asthma. Int J Nurs Stud 2000;37(2):127-133.

    OpenUrlPubMed
31. 31.↵
    1. Breslin E,
    2. van der Schans C,
    3. Breukink S,
    4. Meek P,
    5. Mercer K,
    6. Volz W,
    7. Louie S

    . Perception of fatigue and quality of life in patients with COPD. Chest 1998;114(4):958-964.

    OpenUrlCrossRefPubMedWeb of Science